Endo puts Vasostrict case against U.S. FDA on hold

Endo International Plc is halting its lawsuit against the U.S. Food And Drug Administration until the end of the year after the agency made new commitments on the regulation relating to the active ingredient in blood pressure medicine Vasostrict.

from Reuters: Health News https://ift.tt/2QVlVYJ